The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Extracellular Adenosine-Mediated Modulation of Regulatory T Cells
Open accessAbstract
Extracellular adenosine-dependent suppression and redirection of pro-inflammatory activities are mediated by the signaling through adenosine receptors on the surface of most immune cells. The immunosuppression by endogenously-produced adenosine is pathophysiologically significant since inactivation of A2A/A2B adenosine receptor (A2AR/A2BR) and adenosine-producing ecto-enzymes CD39/CD73 results in the higher intensity of immune response and exaggeration of inflammatory damage. Regulatory T cells (Treg) can generate extracellular adenosine, which is implicated in the immunoregulatory activity of Tregs. Interestingly, adenosine has been shown to increase the numbers of Tregs and further promotes their immunoregulatory activity. A2AR-deficiency in Tregs reduces their immunosuppressive efficacy in vivo. Thus, adenosine is not only directly and instantly inhibiting to the immune response through interaction with A2AR/A2BR on the effector cells, but also adenosine signaling can recruit other immunoregulatory mechanisms, including Tregs. Such interaction between adenosine and Tregs suggests the presence of a positive feedback mechanism, which further promotes negative regulation of immune system through the establishment of immunosuppressive microenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K.-N., & Linden, J. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01511-4 · Cited by 2,585
Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J.-F., Enjyoji, K., Linden, J., Oukka, M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062512 · Cited by 2,470
Hypoxia in cancer: significance and impact on clinical outcome
Vaupel, P., & Mayer, A. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9055-1 · Cited by 2,240
Shi, L. Z., Wang, R., Huang, G., Vogel, P., Neale, G., Green, D. R., & Chi, H. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110278 · Cited by 1,803
Immunosuppressive Strategies that are Mediated by Tumor Cells
Rabinovich, G. A., Gabrilovich, D., & Sotomayor, E. M. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141609 · Cited by 1,702
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
Dang, E. V., Barbi, J., Yang, H.-Y., Jinasena, D., Yu, H., Zheng, Y., Bordman, Z., Fu, J., Kim, Y., Yen, H.-R., et al. (2011) · Cell · doi:10.1016/j.cell.2011.07.033 · Cited by 1,595
Ohta, A., & Sitkovsky, M. (2001) · Nature · doi:10.1038/414916a · Cited by 1,334
Self-citationFredholm, B. B., IJzerman, A. P., Jacobson, K. A., Linden, J., & Müller, C. E. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003285 · Cited by 1,301
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
Haskó, G., Linden, J., Cronstein, B., & Pacher, P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2638 · Cited by 1,217
A2A adenosine receptor protects tumors from antitumor T cells
Ohta, A., Gorelik, E., Prasad, S. J., Ronchese, F., Lukashev, D., Wong, M. K. K., Huang, X., Caldwell, S., Liu, K., Smith, P., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605251103 · Cited by 1,065
Self-citationControl of peripheral T‐cell tolerance and autoimmunity via the CTLA‐4 and PD‐1 pathways
Fife, B. T., & Bluestone, J. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00662.x · Cited by 1,054
Okazaki, T., Chikuma, S., Iwai, Y., Fagarasan, S., & Honjo, T. (2013) · Nature Immunology · doi:10.1038/ni.2762 · Cited by 916
Adenosine receptors as drug targets — what are the challenges?
Chen, J.-F., Eltzschig, H. K., & Fredholm, B. B. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3955 · Cited by 895
Advances in graft-versus-host disease biology and therapy
Blazar, B. R., Murphy, W. J., & Abedi, M. (2012) · Nature Reviews Immunology · doi:10.1038/nri3212 · Cited by 880
Rudensky, A. Y. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01018.x · Cited by 765
Development and Maintenance of Regulatory T cells
Ohkura, N., Kitagawa, Y., & Sakaguchi, S. (2013) · Immunity · doi:10.1016/j.immuni.2013.03.002 · Cited by 728
Purinergic Signaling during Inflammation
Eltzschig, H. K., Sitkovsky, M. V., & Robson, S. C. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1205750 · Cited by 706
Self-citationSitkovsky, M. V., Lukashev, D., Apasov, S., Kojima, H., Koshiba, M., Caldwell, C., Ohta, A., & Thiel, M. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104731 · Cited by 696
Self-citationSynnestvedt, K., Furuta, G. T., Comerford, K. M., Louis, N. A., Karhausen, J., Eltzschig, H. K., Hansen, K. R., Thompson, L. F., & Colgan, S. P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15337 · Cited by 679
Synnestvedt, K., Furuta, G. T., Comerford, K. M., Louis, N., Karhausen, J., Eltzschig, H. K., Hansen, K. R., Thompson, L. F., & Colgan, S. P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215337 · Cited by 660
Cyclic adenosine monophosphate is a key component of regulatory T cell–mediated suppression
Bopp, T., Becker, C., Klein, M., Klein-Heßling, S., Palmetshofer, A., Serfling, E., Heib, V., Becker, M., Kubach, J., Schmitt, S., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062129 · Cited by 658
Purinergic Signaling during Inflammation
(2013) · New England Journal of Medicine · doi:10.1056/nejmc1300259 · Cited by 608
Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
Stagg, J., Divisekera, U., McLaughlin, N., Sharkey, J., Pommey, S., Denoyer, D., Dwyer, K. M., & Smyth, M. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908801107 · Cited by 572
Clambey, E. T., McNamee, E. N., Westrich, J. A., Glover, L. E., Campbell, E. L., Jedlicka, P., de Zoeten, E. F., Cambier, J. C., Stenmark, K. R., Colgan, S. P., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202366109 · Cited by 560
Huang, S., Apasov, S., Koshiba, M., & Sitkovsky, M. (1997) · Blood · doi:10.1182/blood.v90.4.1600 · Cited by 531
Self-citationZarek, P. E., Huang, C.-T., Lutz, E. R., Kowalski, J., Horton, M. R., Linden, J., Drake, C. G., & Powell, J. D. (2008) · Blood · doi:10.1182/blood-2007-03-081646 · Cited by 515
Kobie, J. J., Shah, P. R., Yang, L., Rebhahn, J. A., Fowell, D. J., & Mosmann, T. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.6780 · Cited by 466
Methotrexate—how does it really work?
Chan, E. S. L., & Cronstein, B. N. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.5 · Cited by 459
(1997) · PubMed · Cited by 433
Jin, D., Fan, J., Wang, L., Thompson, L. F., Liu, A., Daniel, B. J., Shin, T., Curiel, T. J., & Zhang, B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3109 · Cited by 432
Adenosine receptors in regulation of dendritic cell differentiation and function
Novitskiy, S. V., Ryzhov, S., Zaynagetdinov, R., Goldstein, A. E., Huang, Y., Tikhomirov, O. Y., Blackburn, M. R., Biaggioni, I., Carbone, D. P., Feoktistov, I., et al. (2008) · Blood · doi:10.1182/blood-2008-02-136325 · Cited by 430 · cited 3×
“Moreover, among other effects of adenosine is the preferential alternative activation of APCs (18, 19) and induction of myeloid-derived suppressor cells (101), both of which lead to inactivation of immune cells.”
BackgroundOhta, A., Kini, R., Ohta, A., Subramanian, M., Madasu, M., & Sitkovsky, M. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00190 · Cited by 398
Self-citationGri, G., Piconese, S., Frossi, B., Manfroi, V., Merluzzi, S., Tripodo, C., Viola, A., Odom, S., Rivera, J., Colombo, M. P., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.018 · Cited by 391
Mandapathil, M., Hilldorfer, B., Szczepanski, M. J., Czystowska, M., Szajnik, M., Ren, J., Lang, S., Jackson, E. K., Gorelik, E., & Whiteside, T. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.047423 · Cited by 390
Cellular Constituents of Immune Escape within the Tumor Microenvironment
Kerkar, S. P., & Restifo, N. P. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4094 · Cited by 370
CD73: a potent suppressor of antitumor immune responses
Beavis, P. A., Stagg, J., Darcy, P. K., & Smyth, M. J. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.02.009 · Cited by 355
Mizumoto, N., Kumamoto, T., Robson, S. C., Sévigny, J., Matsue, H., Enjyoji, K., & Takashima, A. (2002) · Nature Medicine · doi:10.1038/nm0402-358 · Cited by 327
Creating immune privilege: active local suppression that benefits friends, but protects foes
Mellor, A. L., & Munn, D. H. (2008) · Nature Reviews Immunology · doi:10.1038/nri2233 · Cited by 327
Adenosine in Bronchoalveolar Lavage Fluid in Asthma
Driver, A. G., Kukoly, C. A., Ali, S., & Mustafa, S. J. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.1.91 · Cited by 307
Thiel, M., Chouker, A., Ohta, A., Jackson, E., Caldwell, C., Smith, P., Lukashev, D., Bittmann, I., & Sitkovsky, M. V. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030174 · Cited by 287
Self-citationIdentification of Ectonucleotidases CD39 and CD73 in Innate Protection during Acute Lung Injury
Eckle, T., Füllbier, L., Wehrmann, M., Khoury, J., Mittelbronn, M., Ibla, J., Rosenberger, P., & Eltzschig, H. K. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.8127 · Cited by 267
Adenosinergic Regulation of the Expansion and Immunosuppressive Activity of CD11b+Gr1+ Cells
Ryzhov, S., Novitskiy, S. V., Goldstein, A. E., Biktasova, A., Blackburn, M. R., Biaggioni, I., Dikov, M. M., & Feoktistov, I. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101225 · Cited by 261
Hypoxia controls CD4+CD25+ regulatory T‐cell homeostasis via hypoxia‐inducible factor‐1α
Ben‐Shoshan, J., Maysel‐Auslender, S., Mor, A., Keren, G., & George, J. (2008) · European Journal of Immunology · doi:10.1002/eji.200838318 · Cited by 260
Morabito, L., Montesinos, M. C., Schreibman, D. M., Balter, L., Thompson, L. F., Resta, R., Carlin, G., Huie, M. A., & Cronstein, B. N. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1554 · Cited by 259
Ectonucleotidases as Regulators of Purinergic Signaling in Thrombosis, Inflammation, and Immunity
Deaglio, S., & Robson, S. C. (2011) · Advances in Pharmacology · doi:10.1016/b978-0-12-385526-8.00010-2 · Cited by 250
Cutting Edge: Critical Role for A2A Adenosine Receptors in the T Cell-Mediated Regulation of Colitis
Naganuma, M., Wiznerowicz, E. B., Lappas, C. M., Linden, J., Worthington, M. T., & Ernst, P. B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.2765 · Cited by 240
CD73: A Novel Target for Cancer Immunotherapy
Zhang, B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1544 · Cited by 236
A2B adenosine receptors in immunity and inflammation
Haskó, G., Csóka, B., Németh, Z. H., Vizi, E. S., & Pacher, P. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.04.001 · Cited by 232
Lennon, P. F., Taylor, C. T., Stahl, G. L., & Colgan, S. P. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.8.1433 · Cited by 229
Ohta, A., Ohta, A., Madasu, M., Kini, R., Subramanian, M., Goel, N., & Sitkovsky, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901247 · Cited by 215
Self-citationHIF-1–dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak
Morote-Garcia, J. C., Rosenberger, P., Kuhlicke, J., & Eltzschig, H. K. (2008) · Blood · doi:10.1182/blood-2007-11-126763 · Cited by 210
Adenosine A2B Receptor Blockade Slows Growth of Bladder and Breast Tumors
Cekic, C., Sag, D., Li, Y., Theodorescu, D., Strieter, R. M., & Linden, J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101845 · Cited by 201
Much Ado about Adenosine: Adenosine Synthesis and Function in Regulatory T Cell Biology
Ernst, P. B., Garrison, J. C., & Thompson, L. F. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000108 · Cited by 199
The anti-inflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites
Gadangi, P., Longaker, M., Naime, D., Levin, R. I., Recht, P. A., Montesinos, M. C., Buckley, M. T., Carlin, G., & Cronstein, B. N. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.5.1937 · Cited by 196
High adenosine plasma concentration as a prognostic index for outcome in patients with septic shock
Martin, C., Leone, M., Viviand, X., Ayem, M.-L., & Guieu, R. (2000) · Critical Care Medicine · doi:10.1097/00003246-200009000-00014 · Cited by 194
T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response
Sitkovsky, M. V. (2009) · Trends in Immunology · doi:10.1016/j.it.2008.12.002 · Cited by 193
Self-citationMontesinos, M. C., Yap, J. S., Desai, A., Posadas, I., McCrary, C. T., & Cronstein, B. N. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200003)43:3<656::aid-anr23>3.0.co;2-h · Cited by 186
Regulatory T Cells as Immunotherapy
Singer, B. D., King, L. S., & D’Alessio, F. R. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00046 · Cited by 183
Mandapathil, M., Szczepanski, M. J., Szajnik, M., Ren, J., Lenzner, D. E., Jackson, E. K., Gorelik, E., Lang, S., Johnson, J. T., & Whiteside, T. L. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1143 · Cited by 182
CD39/Adenosine Pathway Is Involved in AIDS Progression
Nikolova, M., Carriere, M., Jenabian, M.-A., Limou, S., Younas, M., Kök, A., Huë, S., Seddiki, N., Hulin, A., Delaneau, O., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002110 · Cited by 177
Guereschi, M. G., Araujo, L. P., Maricato, J. T., Takenaka, M. C., Nascimento, V. M., Vivanco, B. C., Reis, V. O., Keller, A. C., Brum, P. C., & Basso, A. S. (2013) · European Journal of Immunology · doi:10.1002/eji.201243005 · Cited by 170
Generation of anti‐inflammatory adenosine byleukocytes is regulated by TGF‐β
Regateiro, F. S., Howie, D., Nolan, K. F., Agorogiannis, E. I., Greaves, D. R., Cobbold, S. P., & Waldmann, H. (2011) · European Journal of Immunology · doi:10.1002/eji.201141512 · Cited by 166
Inflammatory Hypoxia: Role of Hypoxia-Inducible Factor
Karhausen, J., Haase, V. H., & Colgan, S. P. (2005) · Cell Cycle · doi:10.4161/cc.4.2.1407 · Cited by 164
Mandapathil, M., Szczepanski, M. J., Szajnik, M., Ren, J., Jackson, E. K., Johnson, J. T., Gorelik, E., Lang, S., & Whiteside, T. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.127100 · Cited by 162
Enhancement of tumor immunotherapy by deletion of the A2A adenosine receptor
Waickman, A. T., Alme, A., Senaldi, L., Zarek, P. E., Horton, M. R., & Powell, J. D. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1155-7 · Cited by 155
Host A2B Adenosine Receptors Promote Carcinoma Growth
Ryzhov, S. V., Novitskiy, S. V., Carbone, D. P., Biaggioni, I., Zaynagetdinov, R., Goldstein, A. E., Dikov, M. M., & Feoktistov, I. (2008) · Neoplasia · doi:10.1593/neo.08478 · Cited by 151
Autocrine Adenosine Signaling Promotes Regulatory T Cell–Mediated Renal Protection
Kinsey, G. R., Huang, L., Jaworska, K., Khutsishvili, K., Becker, D. A., Ye, H., Lobo, P. I., & Okusa, M. D. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012010070 · Cited by 150
Activation of Adenosine 2A Receptors Attenuates Allograft Rejection and Alloantigen Recognition
Sevigny, C. P., Li, L., Awad, A. S., Huang, L., MCDUFFIE, M. J., Linden, J. M., Lobo, P. I., & Okusa, M. D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4240 · Cited by 147
Raskovalova, T., Lokshin, A. E., Huang, X., Su, Y., Mandić, M., Zarour, H. M., Jackson, E. K., & Gorelik, E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4249 · Cited by 142
Addi, A. B., Lefort, A., Hua, X., Libert, F., Communi, D., Ledent, C. A., Macours, P., Tilley, S. L., Boeynaems, J., & Robaye, B. (2008) · European Journal of Immunology · doi:10.1002/eji.200737781 · Cited by 136
Kobayashi, S., Zimmermann, H., & Millhorn, D. E. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740621.x · Cited by 128
Volmer, J. B., Thompson, L. F., & Blackburn, M. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.4449 · Cited by 124
Adenosine regulates CD8 T‐cell priming by inhibition of membrane‐proximal T‐cell receptor signalling
Linnemann, C., Schildberg, F. A., Schurich, A., Diehl, L., Hegenbarth, S. I., Endl, E., Lacher, S. K., Müller, C. E., Frey, J., Simeoni, L., et al. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03075.x · Cited by 124
Interferon-α Suppresses cAMP to Disarm Human Regulatory T Cells
Bacher, N., Raker, V., Hofmann, C., Graulich, E., Schwenk, M., Baumgrass, R., Bopp, T., Zechner, U., Merten, L., Becker, C., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3788 · Cited by 124
Narravula, S., Lennon, P., Mueller, B. U., & Colgan, S. P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.9.5262 · Cited by 121
CD73 + regulatory T cells contribute to adenosine‐mediated resolution of acute lung injury
Ehrentraut, H., Clambey, E. T., McNamee, E. N., Brodsky, K. S., Ehrentraut, S., Poth, J. M., Riegel, A. K., Westrich, J. A., Colgan, S. P., & Eltzschig, H. K. (2013) · The FASEB Journal · doi:10.1096/fj.12-225201 · Cited by 113
Ring, S., Oliver, S. J., Cronstein, B. N., Enk, A., & Mahnke, K. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.03.022 · Cited by 111
Ehrentraut, H., Westrich, J. A., Eltzschig, H. K., & Clambey, E. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032416 · Cited by 110
Sauer, A. V., Brigida, I., Carriglio, N., Hernández, R. J., Scaramuzza, S., Clavenna, D., Sanvito, F., Poliani, P. L., Gagliani, N., Carlucci, F., et al. (2011) · Blood · doi:10.1182/blood-2011-07-366781 · Cited by 109
Tang, T., Song, Y. S., Ding, Y., Liao, Y., Yu, X., Du, R. H., Xiao, H., Yuan, J., Zhou, Z.-H., Liao, M., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m010876 · Cited by 98
Kim, Y. C., Kim, K. K., & Shevach, E. M. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03269.x · Cited by 96
Control of IFN-αA by CD73: Implications for Mucosal Inflammation
Louis, N. A., Robinson, A., MacManus, C. F., Karhausen, J., Scully, M. M., & Colgan, S. P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.4246 · Cited by 94
Deficiency of CD73/ecto-5′-nucleotidase in mice enhances acute graft-versus-host disease
Tsukamoto, H., Chernogorova, P., Ayata, C. K., Gerlach, U. V., Rughani, A., Ritchey, J. W., Ganesan, J., Follo, M., Zeiser, R., Thompson, L. F., et al. (2012) · Blood · doi:10.1182/blood-2011-09-375899 · Cited by 91
Cyclic AMP underpins suppression by regulatory T cells
Bodor, J., Bopp, T., Vaeth, M., Klein, M., Serfling, E., Hünig, T., Becker, C., Schild, H., & Schmitt, E. (2012) · European Journal of Immunology · doi:10.1002/eji.201141578 · Cited by 88
Alam, M. S., Kurtz, C. C., Wilson, J. M., Burnette, B. R., Wiznerowicz, E. B., Ross, W. G., Rieger, J. M., Figler, R. A., Linden, J. M., Crowe, S. E., et al. (2009) · Mucosal Immunology · doi:10.1038/mi.2009.4 · Cited by 88
Niemelä, J., Henttinen, T. A., Yegutkin, G. G., Airas, L. M., Kujari, A.-M., Rajala, P., & Jalkanen, S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1646 · Cited by 86
Interplay of Hypoxia and A2B Adenosine Receptors in Tissue Protection
Koeppen, M., Eckle, T. D. L. G., & Eltzschig, H. K. (2011) · Advances in pharmacology · doi:10.1016/b978-0-12-385526-8.00006-0 · Cited by 80
Becker, C., Taube, C., Bopp, T., Becker, C., Michel, K. D., Kubach, J., Reuter, S., Dehzad, N., Neurath, M. F., Reifenberg, K., et al. (2009) · Blood · doi:10.1182/blood-2009-02-206730 · Cited by 79
Whiteside, T. L., & Jackson, E. K. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00212 · Cited by 70
Lee, D. J., & Taylor, A. W. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300182 · Cited by 69
Enhanced airway reactivity and inflammation in A2Aadenosine receptor-deficient allergic mice
Nadeem, A., Fan, M., Ansari, H. R., Ledent, C. A., & Mustafa, S. J. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00416.2006 · Cited by 63
Jarvis, M. F., Yu, H., McGaraughty, S., Wismer, C. T., Mikusa, J. P., Zhu, C., Chu, K. L., Kohlhaas, K. L., Cowart, M., Lee, C., et al. (2002) · Pain · doi:10.1016/s0304-3959(01)00435-3 · Cited by 54
Potentiation of neutrophil cyclooxygenase-2 by adenosine: an early anti-inflammatory signal
Cadieux, J.-S., Leclerc, P., St‐Onge, M., Dussault, A., Laflamme, C., Picard, S., Ledent, C. A., Borgeat, P., & Pouliot, M. (2005) · Journal of Cell Science · doi:10.1242/jcs.01737 · Cited by 54
Mohsenin, A., Mi, T., Xia, Y., Kellems, R. E., Chen, J., & Blackburn, M. R. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00187.2007 · Cited by 53
Resta, R., Hooker, S. W., Laurent, A. B., Rahman, S. M. J., FRANKLIN, M. W., Knudsen, T. B., Nadon, N. L., & Thompson, L. F. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119211 · Cited by 51
Han, K. L., Thomas, S. V. M., Koontz, S. M., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201325 · Cited by 50
Hofer, S., Ivarsson, L., Stoitzner, P., Auffinger, M., Romani, N., Heufler, C., & Rainer, C. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12369.x · Cited by 47
Induction of Alloantigen-Specific Human T Regulatory Cells by Vasoactive Intestinal Peptide
Pozo, D., Anderson, P. O., & González‐Rey, E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900400 · Cited by 46
Ohtsuka, T., Changelian, P. S., Bouïs, D., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901847 · Cited by 41
Klein, M., Vaeth, M., Scheel, T., Grabbe, S., Baumgrass, R., Berberich‐Siebelt, F., Bopp, T., Schmitt, E., & Becker, C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102045 · Cited by 41
Meijer, P., Oyen, W. J. G., Dekker, D., van den Broek, P. H. H., Wouters, C. W., Boerman, O. C., Scheffer, G. J., Smits, P., & Rongen, G. A. P. J. M. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.179622 · Cited by 38
Renal interstitial concentration of adenosine during endotoxin shock
Nishiyama, A., Miura, K., Miyatake, A., et al. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00716-5 · Cited by 30
Grenz, A., Zhang, H., Weingart, J., von Wietersheim, S., Eckle, T. D. L. G., Schnermann, J., Köhle, C., Kloor, D., Gleiter, C. H., Vallon, V., et al. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00243.2007 · Cited by 27
Thyroid hormone stimulates 5′-ecto-nucleotidase of neonatal rat ventricular myocytes
Carneiro‐Ramos, M. S., da Silva, V. B., Júnior, M. B. C., Battastini, A. M. O., Sarkis, J. J. F., & Barreto‐Chaves, M. L. M. (2004) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000044396.31443.a8 · Cited by 26
Regulatory T Cells and Transplantation Tolerance
Hilbrands, R., Howie, D., Cobbold, S. P., & Waldmann, H. (2013) · Immunotherapy · doi:10.2217/imt.13.69 · Cited by 26
Distinctive immunoregulatory effects of adenosine on T cells of older humans
Hesdorffer, C. S., Malchinkhuu, E., Biragyn, A., Mabrouk, O. S., Kennedy, R. T., Madara, K., Taub, D. D., Longo, D. L., Schwartz, J. B., Ferrucci, L., et al. (2011) · The FASEB Journal · doi:10.1096/fj.11-197046 · Cited by 16
Cited by
Metabolism of immune cells in cancer
Leone, R. D., & Powell, J. D. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0273-y · Cited by 877
Targeting immunosuppressive adenosine in cancer
Vijayan, D., Young, A., Teng, M. W. L., & Smyth, M. J. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.86 · Cited by 840
Purinergic regulation of the immune system
Cekic, C., & Linden, J. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.4 · Cited by 787
Reversing T-cell Dysfunction and Exhaustion in Cancer
Zarour, H. M. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1849 · Cited by 462
A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment
Ohta, A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00109 · Cited by 385
Self-citation
Metadata
- Authors
- Ohta, A., & Sitkovsky, M.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2014-07-10
- Volume
- 5
- Pages
- 304-304
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W1995858393
- Cited by
- 320
- References
- 108
- FWCI
- 14.26
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.